Peritoneal Cancer
📧 Sign up to get email alerts when something new happens for Peritoneal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-01-11Clinical Trial Update: AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial of AMG 706 in persistent or recurrent ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal cancer was termi…
-
CLINICAL_TRIALS trial_result · 2018-01-03Clinical Trial Update: Effect of Acetylcysteine With Topotecan Hydrochloride on the Tumor Microenvironment in Patients With Persistent or Recurrent High Grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial evaluating acetylcysteine with topotecan hydrochloride in patients with persistent or recurrent high-grade ovarian, fallopian …
-
CLINICAL_TRIALS trial_result · 2017-12-13Clinical Trial Update: Cytoreduction With or Without Intraoperative Intraperitoneal Hyperthermic Chemotherapy (HIPEC) in Patients With Peritoneal Carcinomatosis From Ovarian Cancer, Fallopian Tube or Primary Peritoneal Carcinoma [Phase 3]
Phase 3 clinical trial evaluating cytoreduction with or without intraoperative intraperitoneal hyperthermic chemotherapy (HIPEC) for periton…
-
CLINICAL_TRIALS trial_result · 2017-12-08Clinical Trial Update: Dalantercept in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer [Phase 2]
Phase 2 trial update for dalantercept in recurrent ovarian, fallopian tube, or primary peritoneal cancer; study completed with results poste…
-
CLINICAL_TRIALS trial_result · 2017-12-05Clinical Trial Update: Intraperitoneal Natural Killer Cells and INCB024360 for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer [Phase 1]
A Phase 1 trial evaluating intraperitoneal natural killer cells in combination with INCB024360 for recurrent ovarian, fallopian tube, and pr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2) [Phase 3]
The Phase 3 TRINOVA-2 trial of trebananib (AMG 386) in fallopian tube cancer, ovarian cancer, and primary peritoneal cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer [Phase 1]
Update on a Phase 1 trial of docetaxel in patients with refractory or recurrent advanced gynecologic cancers, with the study status marked a…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies [Phase 1]
This is a completed Phase 1 trial evaluating hyperthermic intraperitoneal oxaliplatin for peritoneal cancers.
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Topotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer [Phase 1]
Phase 1 trial of topotecan in fallopian tube cancer, ovarian cancer, or primary peritoneal cancer; the study status is terminated.
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients [Phase 1]
Phase I study evaluating ABT-888 (veliparib) with temozolomide in patients with various cancers, including metastatic melanoma. The trial st…
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: Enzastaurin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial of enzastaurin in patients with persistent or recurrent ovarian epithelial cancer or primary peritoneal cancer has co…
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: Veliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal Cancer [Phase 1]
Phase 1 trial evaluating veliparib in combination with radiation therapy in adults with advanced solid tumors featuring peritoneal carcinoma…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Intraoperative Detection of Lesions Using PET (Positron Emission Tomography) Probe During Secondary Cytoreductive Surgery for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancer [NA]
This study assessed intraoperative detection of cancer lesions using a PET probe during secondary cytoreductive surgery for recurrent ovaria…
-
CLINICAL_TRIALS trial_result · 2017-10-02Clinical Trial Update: Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 1]
Phase 1 clinical trial evaluating recombinant measles virus vaccine therapy and oncolytic virus therapy for progressive, recurrent, or refra…
-
CLINICAL_TRIALS trial_result · 2017-09-07Clinical Trial Update: Rilotumumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial of rilotumumab in persistent/recurrent ovarian, fallopian tube, or primary peritoneal cancer has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2017-09-06Clinical Trial Update: OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission [Phase 2]
Phase 2 clinical trial evaluating OPT-821 with or without vaccine therapy in ovarian, fallopian tube, or primary peritoneal cancer in second…
-
CLINICAL_TRIALS trial_result · 2017-08-28Clinical Trial Update: Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy [Phase 2]
This Phase 2 trial evaluated the combination of sargramostim with paclitaxel albumin-stabilized nanoparticle formulation in patients with ad…
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: Karenitecin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
The document reports the completion of a Phase 2 clinical trial evaluating Karenitecin for persistent or recurrent ovarian epithelial cancer…
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: CT-2103 in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial CT-2103 for recurrent or persistent ovarian epithelial cancer or primary peritoneal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-12Clinical Trial Update: Bevacizumab With or Without Fosbretabulin Tromethamine in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer [Phase 2]
Phase 2 trial evaluating bevacizumab with or without fosbretabulin tromethamine in recurrent or persistent ovarian epithelial, fallopian tub…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer [Phase 2]
Phase II trial evaluating bevacizumab followed by consolidation therapy for advanced ovarian cancer and related tumors; results have been po…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Cediranib Maleate in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer [Phase 2]
Phase 2 clinical trial evaluating cediranib maleate in patients with persistent, recurrent, or refractorily advanced ovarian epithelial, fal…
-
CLINICAL_TRIALS trial_result · 2017-06-09Clinical Trial Update: Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal Cancer [Phase 2]
A Phase 2 trial conducted by GlaxoSmithKline evaluating a second-line intravenous therapy for recurrent platinum-sensitive ovarian, fallopia…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: RO4929097 in Treating Patients With Recurrent and/or Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial of RO4929097 in recurrent/metastatic epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer has compl…
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: A Study of Bevacizumab in Ovarian Cancer or Primary Peritoneal Cancer Where Doxil or Topotecan Therapy Has Failed [Phase 2]
This clinical trial update reports the completion of a Phase 2 study evaluating bevacizumab in patients with ovarian cancer or primary perit…